July 26, 2019 at 1:44 pm

Drug Risks Should be Clearly Communicated

Prescription drug withdrawal can sometimes lead to permanent prescriptions. “Ten years on and I am still taking that antipsychotic, not because it proved to be an effective mood stabilizer, not because it improves my health in any way, but simply because I am physically incapable of sleep without it.”
Read the full article here.
July 25, 2019 at 2:28 pm

Drug Safety Label Changes: A Target for Collaboration
“Communicating the most up-to-date information on a product’s safety to patients and providers is one of FDA’s most important functions,” said Mark McClellan, MD, PhD, director of Duke Margolis Center for Health Policy.
Collaboration is needed to help the FDA increase its understanding of the impact of postmarketing drug safety. Read the full press release here.
July 22, 2019 at 5:21 pm

A Solution to Increasingly High Drug Prices?

High drug costs can lead to people skipping their prescriptions. This can lead to many serious adverse drug effects to include withdrawal akathisia. Read the full article here.
July 20, 2019 at 1:30 pm

HIV Patients File New Lawsuit Over Adverse Drug Effects

Two new lawsuits charge many patients taking a Gilead HIV drug “needlessly suffered debilitating and sometimes fatal kidney and bone damage as well as damage to their teeth.” Read the full article here.
July 20, 2019 at 10:48 am

11.9K New Views to MISSD YouTube Channel

MISSD can’t help but be thrilled with these new analytics: More than 11.9K new views to our YouTube Channel in less than 90 days. Viewers from across the globe include India, USA, Saudi Arabia, Canada…
We are grateful to all who help us increase awareness of adverse drug effects.
July 19, 2019 at 1:37 pm

Drug Risks Often Identified After FDA Approval

Sixty two percent of this specific drug class received the FDA’s most stringent warning, known as a “black box.” Most of the serious adverse effects were identified only after the drugs were on the market.
 “It raises the question of should we be regulating them differently,” said Joseph Ross, an associate professor of medicine at Yale School of Medicine, who has studied drug safety. Read the full article here.


July 17, 2019 at 10:18 am

Podcast Series Features MISSD Board Member’s Akathisia Story

Experts by experience is a term increasingly used to describe healthcare consumers and their families who share factual, first-hand experiences relating to pharmaceutical products and doctors’ care.  Gail Regenbogen, a MISSD board member, discusses her late husband, Howard’s, prescribed demise in our second  Akathisia Stories podcast.
Please listen and share so that others can be safer and better informed regarding critical adverse drug effects. Gail eloquently tells her family’s story with profound wisdom acquired after Howard’s akathisia-induced death. Listen here.


July 12, 2019 at 11:55 am

Akathisia Ads Taking Off in Chicago

MISSD is thrilled to reach 500 FB likes today. But even better is that our new Akathisia Awareness ads are taking off on many new Chicago train lines.  Way to roll!

July 9, 2019 at 3:50 am

MISSD Presents Akathisia Info at London Conference

Hundreds of doctors learned more about akathisia during MISSD’s recent presentation at the Royal College of Psychiatrists’ International Congress. Wendy Dolin shared case studies and MISSD videos that highlight the external and internal symptoms doctors should look for when assessing for akathisia.